Board Certified Oncology Pharmacist 2000
Hematology/Oncology Pharmacy Practice
Dana Farber Cancer Institute
McCormick M, Awo Osei-Anto H, Martinez RM, Editors; Committee on Addressing Sickle Cell Disease. National Academies of Sciences, Engineering, and Medicine 2020. Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action. Washington, DC: The National Academies Press. https://doi.org/10.17226/25632 .
Fang K, Orr-Skirvin JA. Review of systemic lupus erythematosus, treatment, and future directions. US Pharm. 2019;44(8)(Specialty&Oncology suppl)3-7.
Okwerekwu, I, Skirvin JA. Sickle Cell Disease Pain Management. US Pharm 2018;43(3)12-18.
Leblebjian H, DeAngelo DJ, Skirvin JA, et. Al. Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia Leuk Res. 2013 Jul;37(7):747-51.
Douglass MA, Casale JP, Skirvin JA, Divall M. A Virtual Patient Software Program to Improve Pharmacy Student Learning in a Comprehensive Disease Management Course. A J Pharm Ed 2013:77;article 172.
Selected Public Service:
AACP Academic Leadership Fellows Program (ALFP) program 2019-2020
National Academies of Science, Engineering & Medicine 2019
Hematology/Oncology Pharmacy Association, Sub-committee on Leadership 2018-2022